Skin pigmentation disorders: More than just cosmetic?
The American Academy of Dermatology estimates that five million to six million Americans will at some point experience a skin pigmentation condition. Of all these disorders, vitiligo has the most devastating effects on the patient's psychosocial and emotional well-being. Other conditions, such as melasma and solar lentigines, may have less disabling psychological effects, but they are not inconsequential. Raising awareness of these skin disorders was recently discussed at a Galderma-sponsored luncheon in New York City.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.